RALBP1 and neoplasm: RAL effector proteins, including RALGEFs and RALBP1, have emerged as important mediators of malignant growth in pancreatic, colorectal, prostate, bladder, and other tumour cell lines characterised by the presence of oncogenic RAS mutations (Neel et al., 2011).